cirm.ca.gov

Clinical Development of ETX101, a Gene Regulation Therapy for SCN1A+ Dravet Syndrome

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
cirm.ca.gov

Demographics, Prevalence, and Characteristics of Limbal Stem Cell Deficiency in Southern California.

Limbal stem cell deficiency (LSCD) is a potentially blinding disease characterized by the loss of the stem cell population. The purpose of this publication is to report the prevalence, incidence and ...
cirm.ca.gov

Androgenetic alopecia.

Yingzi Liu, Antonella Tosti, Etienne C E Wang, Stefanie Heilmann-Heimbach, Crystal Aguh, Francisco Jimenez, Sung-Jan Lin, Ohsang Kwon, Maksim V Plikus Androgenetic alopecia (AGA) is a condition of ...
cirm.ca.gov

Effects of PDMS culture on stem cell differentiation towards definitive endoderm and hepatocytes.

Keywords: Induced pluripotent stem cells; Liver tissue engineering; Mechanosensing; PDMS; Substrate stiffness. The generation of human induced pluripotent stem cell (hiPSC) derivatives for ...
cirm.ca.gov

Complementary biomolecular coassemblies direct energy transport for cardiac photostimulators.

Ze-Fan Yao, Sujeung Lim, Yuyao Kuang, Emil M Lundqvist, Natalie Celt, Caleb O Chung, Kathryn K Lee, Krystal Nguyen, Lanie Le, Sheng Wei Tang, Griffin M Milligan, Phillip Kohl, Tarunya Rao Sudarshan, ...
cirm.ca.gov

CIRM Awards $67.5 Million to Address Neuropsychiatric Diseases through its ReMIND Program

South San Francisco, CA, August 30, 2024 – The California Institute for Regenerative Medicine, one of the world’s largest institutes dedicated to regenerative medicine, approved $67.5 million to ...
cirm.ca.gov

CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
cirm.ca.gov

Research Training Grant

The mission of California Institute for Regenerative Medicine (CIRM) is to accelerate stem cell treatments to patients with unmet medical needs. The overall objective of the CIRM Research Training ...
cirm.ca.gov

CIRM approves $73 million in awards for discovery research

South San Francisco, CA, September 25, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding more than $73 million across 23 grants to support discovery research ...
cirm.ca.gov

CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities

South San Francisco, Calif., October 30, 2025 – The California Institute for Regenerative Medicine (CIRM) has approved awarding $27 million through three grants across the state to create a network of ...
cirm.ca.gov

CIRM awards $26 million to advance clinical research across cancer, heart conditions, and rare diseases

South San Francisco, CA, June 28, 2024 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $26 million to ...
cirm.ca.gov

CIRM awards $4.7 million for vision loss gene therapy

South San Francisco, CA, May 29, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, awarded $4.7 million to ...